These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11896331

  • 1. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.
    Cid J, Ortin X, Elies E, Castellà D, Panadés M, Martín-Vega C.
    Transfusion; 2002 Feb; 42(2):173-6. PubMed ID: 11896331
    [Abstract] [Full Text] [Related]

  • 2. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets.
    Molnar R, Johnson R, Sweat LT, Geiger TL.
    Transfusion; 2002 Feb; 42(2):177-82. PubMed ID: 11896332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.
    Cid J, Lozano M, Ziman A, West KA, O'Brien KL, Murphy MF, Wendel S, Vázquez A, Ortín X, Hervig TA, Delaney M, Flegel WA, Yazer MH, Biomedical Excellence for Safer Transfusion collaborative.
    Br J Haematol; 2015 Feb; 168(4):598-603. PubMed ID: 25283094
    [Abstract] [Full Text] [Related]

  • 5. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases.
    Cid J, Lozano M, Fernández-Avilés F, Carreras E, Pereira A, Mazzara R, Ordinas A.
    Transfusion; 2006 Feb; 46(2):169-73. PubMed ID: 16441590
    [Abstract] [Full Text] [Related]

  • 6. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A.
    Blood; 1995 Feb 01; 85(3):824-8. PubMed ID: 7833483
    [Abstract] [Full Text] [Related]

  • 7. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors].
    Duboeuf S, Flourié F, Courbil R, Oriol P, Benamara A, Chartier M, Rigal E, Garraud O.
    Ann Biol Clin (Paris); 2009 Feb 01; 67(3):353-7. PubMed ID: 19411240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P, Josset V, Bastit D, Tavolacci MP, Lenain P, Varin R, Czernichow P.
    Transfus Clin Biol; 2005 Oct 01; 12(4):306-12. PubMed ID: 16169273
    [Abstract] [Full Text] [Related]

  • 11. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.
    Lozano M, Cid J.
    Transfus Med Rev; 2003 Jan 01; 17(1):57-68. PubMed ID: 12522772
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
    Lin Y, Saskin A, Wells RA, Lenis M, Mamedov A, Callum J, Buckstein R.
    Vox Sang; 2017 Jan 01; 112(1):79-86. PubMed ID: 28097704
    [Abstract] [Full Text] [Related]

  • 14. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF.
    Br J Haematol; 2000 Dec 01; 111(3):980-3. PubMed ID: 11122163
    [Abstract] [Full Text] [Related]

  • 15. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A.
    Transfusion; 2013 Apr 01; 53(4):710-5. PubMed ID: 22845746
    [Abstract] [Full Text] [Related]

  • 16. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group.
    N Engl J Med; 1997 Dec 25; 337(26):1861-9. PubMed ID: 9417523
    [Abstract] [Full Text] [Related]

  • 17. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
    Leisch M, Weiss L, Lindlbauer N, Jungbauer C, Egle A, Rohde E, Greil R, Grabmer C, Pleyer L.
    Leuk Res; 2017 Aug 25; 59():12-19. PubMed ID: 28535394
    [Abstract] [Full Text] [Related]

  • 18. Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusion.
    Yazer MH, Brunker PA, Bakdash S, Tobian AA, Triulzi DJ, Earnest V, Harris S, Delaney M.
    Transfusion; 2016 Oct 25; 56(10):2502-2509. PubMed ID: 27401270
    [Abstract] [Full Text] [Related]

  • 19. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs.
    Boctor FN, Ali NM, Mohandas K, Uehlinger J.
    Transfusion; 2003 Feb 25; 43(2):173-6. PubMed ID: 12559012
    [Abstract] [Full Text] [Related]

  • 20. Anti-E alloimmunization from a platelet apheresis transfusion in a 22-month-old male with acute myeloid leukemia.
    Burks M, Warren CS, Lightfoot T, Fadeyi EA.
    Lab Med; 2024 Jul 03; 55(4):517-519. PubMed ID: 38346103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.